HOME >> BIOLOGY >> NEWS
Genome study of beneficial microbe may help boost plant health

ROCKVILLE, Md - In a study expected to greatly benefit crop plants, scientists have deciphered the genome of a root- and seed-dwelling bacterium that protects plants from diseases.

The research provides clues to better explain how the helpful microbe, Pseudomonas fluorescens Pf-5, naturally safeguards roots and seeds from infection by harmful microbes that cause plant diseases. The genome paper will be published in Nature Biotechnology and was scheduled to be posted online on June 26.

"The genome sequence has helped us identify new chemical pathways that the microbe apparently uses to create what are known as 'secondary metabolites' possibly including new antibiotic compounds," says Ian Paulsen. He led the sequencing at The Institute for Genomic Research (TIGR), Rockville, Md., and is the study's first author.

The use of naturally-occurring, beneficial microbes such as P. fluorescens to control plant pathogens is called "biological control." That method is gaining momentum as a way to grow healthy plants without using synthetic fungicides. In all, about three dozen beneficial microbes are currently used as an environmentally-friendly way to fight plant diseases.

Joyce E. Loper, senior author of the genome paper and an expert on P. fluorescens Pf-5, predicts that the new genomic data will help scientists more quickly develop new ways to boost the effectiveness of beneficial microbes in fighting plant diseases.

"This genomic sequence reveals previously unknown traits of P. fluorescens that increase its potential for biological control," says Loper. She is a plant pathologist with USDA's Agricultural Research Service (ARS) and is based at Oregon State University, Corvallis. The P. fluorescens genome was sequenced at TIGR and analyzed by scientists there and at ARS and Oregon State University, with contributions by researchers at Rutgers, Washington State University and the University of Arizona. The proj
'"/>

Contact: Robert Koenig
rkoenig@tigr.org
301-795-7880
The Institute for Genomic Research
26-Jun-2005


Page: 1 2

Related biology news :

1. The Cancer Genome Atlas awards funds for technology development
2. DOE Joint Genome Institute secures long-term lease on production genomics facility
3. DOE JGI upgrades its Microbial Genome Analysis System
4. Genome of Clostridium botulinum reveals the background to worlds deadliest toxin
5. Genome Canada, Gnome Qubec and Universit de Montral launch P3G Consortium and CARTaGENE Project
6. Genome of yellow fever/dengue fever mosquito sequenced
7. Genome-wide search unearths surprising clues for diabetes and triglycerides
8. Latest advances in DNA sequencing highlighted at DOE Joint Genome Institute User Meeting
9. No pain, DOE Joint Genome Institute gains coveted ergonomics prize with Shake N Plate
10. DOE JGI releases enhanced Genome Data Management System IMG 2.1 marking 2-year anniversary
11. Genome sequencing reveals key to viable ethanol production

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Genome study beneficial microbe may help boost plant health

(Date:5/21/2013)... Researchers at USC have found that a class of ... mice. , The drugs, known as "TSPO ligands," ... "We looked at the effects of TSPO ligand in ... stage, and in aged mice when pathology was quite ... Davis School of Gerontology. "TSPO ligand reduced measures of ...
(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...
(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
(Date:5/21/2013)... Alpha Source, Inc., a Wisconsin-based ... exhibiting for the 13th consecutive year at the ... 2013 Conference and Expo. The conference brings together ... healthcare technologies. This year’s event will be held ... , The three-day event draws over 1,500 healthcare ...
(Date:5/21/2013)... New York , May 21, 2013 ... by Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products ... Research, IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, ... 2.4 billion in 2011 and is expected to grow ... to reach an estimated value of USD 4.7 billion ...
(Date:5/21/2013)... 21, 2013  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... serious infectious diseases, announced today that Jeffrey Riley ... Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 ... Grand Hyatt Hotel. Mr. Riley is scheduled to present at ... Synthetic Biologics, presentation can be accessed by logging onto the ...
(Date:5/21/2013)... Inflamax scientists worked closely with ... design the study, which will provide critical insight ... used in the study of allergy treatments, the ... (NAC) models. Although both the models are well ... no direct comparison between the allergic responses evoked ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2
Cached News: